CAS 180915-93-9
:ent-Lasofoxifene
Description:
Ent-Lasofoxifene is a selective estrogen receptor modulator (SERM) that exhibits tissue-selective estrogenic activity, primarily used in the context of treating conditions related to estrogen deficiency, such as osteoporosis. It is characterized by its ability to bind to estrogen receptors, influencing gene expression in a manner that mimics estrogen in some tissues while blocking its effects in others. This dual action allows ent-Lasofoxifene to promote bone density and potentially reduce the risk of fractures without stimulating breast or uterine tissue, thereby minimizing the risk of estrogen-related cancers. The compound has a specific chemical structure that contributes to its pharmacological properties, and it is typically administered in a pharmaceutical formulation. Its efficacy and safety profile have been the subject of clinical studies, highlighting its potential benefits and side effects. As with any medication, it is essential to consider individual patient factors and consult healthcare professionals for appropriate use.
Formula:C28H31NO2
Synonyms:- ent-Lasofoxifene
- 2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-, (5S,6R)-
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
